Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hospice × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 5432 Neoplasms 4539 Prostatic Neoplasms 2528 Colorectal Neoplasms 2269 Carcinoma, Non-Small-Cell Lung 2262 Lung Neoplasms 1912 Multiple Myeloma 1405 Lymphoma 1360 Neoplasm Metastasis 1332 Leukemia, Myeloid, Acute 1295 Melanoma 1271 Pancreatic Neoplasms 1250 Ovarian Neoplasms 1209 Leukemia 1184 Head and Neck Neoplasms 1075 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1067 Lymphoma, Non-Hodgkin 1026 Colonic Neoplasms 970 Carcinoma, Hepatocellular 961 Stomach Neoplasms 956 Leukemia, Lymphocytic, Chronic, B-Cell 914 Brain Neoplasms 909 Rectal Neoplasms 836 Recurrence 817 Lymphoma, Follicular 815 Uterine Cervical Neoplasms 789 Glioblastoma 784 Carcinoma, Renal Cell 746 Lymphoma, Large B-Cell, Diffuse 712 Hodgkin Disease 658

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡